Updated review of advances in microRNAs and complex diseases: experimental results, databases, webservers and data fusion

L Huang, L Zhang, X Chen - Briefings in bioinformatics, 2022 - academic.oup.com
MicroRNAs (miRNAs) are gene regulators involved in the pathogenesis of complex
diseases such as cancers, and thus serve as potential diagnostic markers and therapeutic …

The microRNA-183 cluster: the family that plays together stays together

S Dambal, M Shah, B Mihelich, L Nonn - Nucleic acids research, 2015 - academic.oup.com
Abstract The microRNA (miR) 183 cluster, which is comprised of miRs-183,-96 and-182, is
also a miR family with sequence homology. Despite the strong similarity in the sequences of …

[HTML][HTML] Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer

Y Zhu, S Wang, X Xi, M Zhang, X Liu, W Tang, P Cai… - Theranostics, 2021 - ncbi.nlm.nih.gov
Abstract Rationale: Long extracellular RNAs (exRNAs) in plasma can be profiled by new
sequencing technologies, even with low abundance. However, cancer-related exRNAs and …

The translational potential of microRNAs as biofluid markers of urological tumours

A Fendler, C Stephan, GM Yousef… - Nature Reviews …, 2016 - nature.com
MicroRNAs (miRNAs) are secreted by cells in vesicles, bound in a ribonucleoprotein
complex or as free molecules. These miRNA secretion pathways are dysregulated in cancer …

[HTML][HTML] miRNAs as novel biomarkers in the management of prostate cancer

X Filella, L Foj - Clinical Chemistry and Laboratory Medicine (CCLM), 2017 - degruyter.com
Abstract microRNAs (miRNAs) are small non-coding RNAs that control gene expression
posttranscriptionally and are part of the giant non codifying genoma. Cumulating data …

[HTML][HTML] The genomic impact of DNA CpG methylation on gene expression; relationships in prostate cancer

MD Long, DJ Smiraglia, MJ Campbell - Biomolecules, 2017 - mdpi.com
The process of DNA CpG methylation has been extensively investigated for over 50 years
and revealed associations between changing methylation status of CpG islands and gene …

[HTML][HTML] The utility of urine-circulating miRNAs for detection of prostate cancer

K Stuopelyte, K Daniunaite, A Bakavicius… - British journal of …, 2016 - nature.com
Background: In this paper, the utility of urine-circulating microRNAs (miRNAs) as the
potential biomarker of prostate cancer (PCa), the second most prevalent male cancer …

A 9-microRNA signature in serum serves as a noninvasive biomarker in early diagnosis of Alzheimer's disease

R Guo, G Fan, J Zhang, C Wu, Y Du… - Journal of …, 2017 - content.iospress.com
Alzheimer's disease (AD) is the most common type of age-related neurodegenerative
disorder; nevertheless, nowadays there are no reliable biomarkers or non-invasive …

[HTML][HTML] Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer

AH Zedan, PJS Osther, J Assenholt, JS Madsen… - Scientific reports, 2020 - nature.com
Metastatic castration resistant prostate cancer (mCRPC) is associated with high mortality,
where monitoring of disease activity is still a major clinical challenge. The role of microRNAs …

Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis

MYC Stafford, CE Willoughby, CP Walsh… - Bioscience …, 2022 - portlandpress.com
Elevated levels of miR-21 expression are associated with many cancers, suggesting it may
be a promising clinical biomarker. In prostate cancer (PCa), however, there is still no …